[1] 谭丽, 张蕾, 朱桂金, TAN Li, ZHANG Lei, ZHU Guijin. 中国汉族人多囊卵巢综合征患者CYP17基因多态性分析 [J]. 郑州大学学报（医学版） 2005.doi:10.3969/j.issn.1671-6825.2005.03.024
[2] 丁玲玲. 山东汉族妇女多囊卵巢综合征CYP17基因多态与高雄激素相关性的研究 [D]. 山东大学 2007.
[3] 王芳. 山东汉族育龄妇女雄激素受体基因微卫星CAG多态性与PCOS相关性研究 [D]. 青岛大学 2007.
[4] 徐玉萍, 曹云霞, 易龙, 王勇, Yu-ping XU, Yun-xia CAO, Long YI, Yong WANG. 胰岛素基因多态性与多囊卵巢综合征的相关性研究 [J]. 生殖与避孕 2008.doi:10.3969/j.issn.0253-357X.2008.09.003
[5] Hao C F, Bao H C, Zhang N. Evaluation of association between the CYP11 alpha promoter pentannucleotide (TTTTA) polymorphism and polycystic ovarian syndrome among Han Chinese women [J]. Neuroendocrinology Letters 2009, 30(01).
[6] Franks S, Charani N, McCarthy M. Candidate genes in polycystic ovary syndrome [J]. Human Reproduction Update 2001, 7(04).
[7] Diamanti Kandarakis E, Piperi C. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. [J]. Human reproduction update 2005, 6(6).
[8] Daneshmand S, Weitsman S R, Navab A. Overexpres-sion of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17-hydroxylase/C (17-20) lyase promoters [J]. Fertility and Sterility 2002, 77(02).
[9] Diamanti-Kandarakis E, Bartzis M I, Zapanti E D. Po-lymorphismT→C(-34bp) of gene CYP17 promoterin Greek patients with polycystic ovary syndrome [J]. Fertility and Sterility 1999, 71(03).
[10] Perez M S, Cerrone G E, Benencia H. Polymorphism in CYP11 alpha and CYP17 genes and the etiology of hyper-androgenism in patients with polycystic ovary syndrome [J]. Medicina(B Aires) 2008, 68(02).
[11] Kahsar Miller M, Boots LR, Bartolucci A, Azziz R. Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome. [J]. Fertility and Sterility 2004, 4(4).
[12] Kim JJ, Choung SH, Choi YM, Yoon SH, Kim SH, Moon SY. [J]. Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society 2008.
[13] Van-Nieuwerburgh F, Stoop D, Cabri P, Dhont M, Deforce D, De-Sutter P. [J]. Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology 2008.
[14] Kevin H N, Cousin P, Pugeat M. Human sex hormone -binding globulin variants associated with hyperandro -genism and ovarian dysfunction [J]. Clinical Investigator 2002, 109(07).
[15] Liu Q, Gu W, Cui B. The association of TAAAA repeat polymorphism in sex hormone-binding protein gene with polycystic ovary syndrome in Chinese population [J]. Endocrinology 2008, 34(1-3).
[16] Calvo RM, Telleria D, Sancho J, San Millan JL, Escobar Morreale HF. Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women. [J]. Fertility and Sterility 2002, 4(4).
[17] Powell BL, Haddad L, Bennett A, Gharani N, Sovio U, Groves CJ, Rush K, Goh MJ, Conway GS, Ruokonen A, Martikainen H, Pouta A, Taponen S, Hartikainen AL, Halford S, Zeggini E, Jarvelin MR, Franks S, McCarthy MI. Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits. [J]. The Journal of Clinical Endocrinology and Metabolism 2005, 5(5).
[18] Lee EJ, Oh B, Lee JY, Kimm K, Lee SH, Baek KH. A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome. [J]. Fertility and Sterility: Official Journal of the American Fertility Society, Pacific Coast Fertility Society, and the Canadian Fertility and Andrology Society 2008, 5(5).
[19] Mukherjee S, Shaikh N, Khavale S, Shinde G, Meherji P, Shah N, Maitra A. Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome. [J]. European journal of endocrinology 2009, 5(5).
[20] Koika V, Marioli DJ, Saltamavros AD. Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome. [J]. European journal of endocrinology 2009, 2(2).
[21] Antoine, HJ, Pall, M, Trader, BC, Chen, YD, Azziz, R, Goodarzi, MO. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome. [J]. Fertility and Sterility 2007, 4(4).
[22] Peral B, San Millan JL, Castello R, Moghetti P, Escobar Morreale HF. Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism. [J]. The Journal of Clinical Endocrinology and Metabolism 2002, 8(8).
[23] Erdogan M, Karadeniz M, Berdeli A, Alper G, Caglayan O, Yilmaz C. The relationship of the interleukin-6 -174 G>C gene polymorphism with oxidative stress markers in Turkish polycystic ovary syndrome patients. [J]. Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology 2008, 7(7).
[24] Escobar Morreale HF, Luque Ramirez M, San Millan JL. [J]. Endocrine Reviews 2005. |
